D V Sheehan

Summary

Affiliation: University of South Florida
Country: USA

Publications

  1. ncbi request reprint Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR
    Stuart A Montgomery
    Imperial College School of Medicine, PO Box 8751, London, UK
    J Psychiatr Res 36:209-17. 2002
  2. ncbi request reprint Differences in total medical costs across the SSRIs for the treatment of depression and anxiety
    David V Sheehan
    Department of Psychiatry and Behavioral Medicine, University of South Florida, 4202 E Fowler Avenue, Tampa, FL 33620, USA
    Am J Manag Care 11:S354-61. 2005
  3. ncbi request reprint The management of panic disorder
    David V Sheehan
    University of South Florida Institute for Research in Psychiatry, Tampa 33613, USA
    J Clin Psychiatry 63:17-21. 2002
  4. ncbi request reprint Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder
    David V Sheehan
    Institute for Research in Psychiatry, Department of Psychiatry, University of South Florida, Tampa, FL 33613 4788, USA
    J Clin Psychiatry 66:34-40. 2005
  5. ncbi request reprint Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data
    D V Sheehan
    Institute for Research in Psychiatry, University of South Florida, Tampa 33613, USA
    J Clin Psychiatry 62:26-31. 2001
  6. doi request reprint Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features
    David V Sheehan
    Depression and Anxiety Disorders Research Institute, University of South Florida College of Medicine, Tampa, Florida 33613, USA
    Int Clin Psychopharmacol 24:61-86. 2009
  7. ncbi request reprint Current concepts in the treatment of panic disorder
    D V Sheehan
    Department of Psychiatry, University of South Florida, USF Institute for Research in Psychiatry, Tampa 36613 4788, USA
    J Clin Psychiatry 60:16-21. 1999
  8. ncbi request reprint Social anxiety disorder
    B A Raj
    Department of Psychiatry, University of South Florida College of Medicine, Tampa, Florida, USA
    Med Clin North Am 85:711-33. 2001
  9. ncbi request reprint Nicotinic acetylcholine receptors as targets for antidepressants
    R D Shytle
    Center for Aging and Brain Repair, Department of Neurosurgery, University of South Florida College of Medicine, Tampa, FL 33613, USA
    Mol Psychiatry 7:525-35. 2002
  10. ncbi request reprint The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder
    David V Sheehan
    Department of Psychiatry, University of South Florida College of Medicine, Tampa, Florida 33613, USA
    Psychopharmacol Bull 40:63-81. 2007

Detail Information

Publications31

  1. ncbi request reprint Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR
    Stuart A Montgomery
    Imperial College School of Medicine, PO Box 8751, London, UK
    J Psychiatr Res 36:209-17. 2002
    ..To characterize the response to the serotonin and norepinephrine reuptake inhibitor, venlafaxine extended release (XR), during the long-term treatment of generalized anxiety disorder...
  2. ncbi request reprint Differences in total medical costs across the SSRIs for the treatment of depression and anxiety
    David V Sheehan
    Department of Psychiatry and Behavioral Medicine, University of South Florida, 4202 E Fowler Avenue, Tampa, FL 33620, USA
    Am J Manag Care 11:S354-61. 2005
    ..Future studies should measure rates of adherence in relation to medical outcomes over an expanded time frame...
  3. ncbi request reprint The management of panic disorder
    David V Sheehan
    University of South Florida Institute for Research in Psychiatry, Tampa 33613, USA
    J Clin Psychiatry 63:17-21. 2002
    ....
  4. ncbi request reprint Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder
    David V Sheehan
    Institute for Research in Psychiatry, Department of Psychiatry, University of South Florida, Tampa, FL 33613 4788, USA
    J Clin Psychiatry 66:34-40. 2005
    ..To assess the efficacy and tolerability of controlled-release paroxetine (paroxetine CR) in the treatment of adults with panic disorder...
  5. ncbi request reprint Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data
    D V Sheehan
    Institute for Research in Psychiatry, University of South Florida, Tampa 33613, USA
    J Clin Psychiatry 62:26-31. 2001
    ..The results of these studies demonstrate the strong potential of venlafaxine XR in facilitating remission in GAD...
  6. doi request reprint Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features
    David V Sheehan
    Depression and Anxiety Disorders Research Institute, University of South Florida College of Medicine, Tampa, Florida 33613, USA
    Int Clin Psychopharmacol 24:61-86. 2009
    ..Venlafaxine was not superior to fluoxetine or placebo in providing remission...
  7. ncbi request reprint Current concepts in the treatment of panic disorder
    D V Sheehan
    Department of Psychiatry, University of South Florida, USF Institute for Research in Psychiatry, Tampa 36613 4788, USA
    J Clin Psychiatry 60:16-21. 1999
    ....
  8. ncbi request reprint Social anxiety disorder
    B A Raj
    Department of Psychiatry, University of South Florida College of Medicine, Tampa, Florida, USA
    Med Clin North Am 85:711-33. 2001
    ..For the first time, there are good data about a range of effective treatment options that can offer these patients substantial relief and protection from their disability...
  9. ncbi request reprint Nicotinic acetylcholine receptors as targets for antidepressants
    R D Shytle
    Center for Aging and Brain Repair, Department of Neurosurgery, University of South Florida College of Medicine, Tampa, FL 33613, USA
    Mol Psychiatry 7:525-35. 2002
    ..If this hypothesis is supported by further preclinical and clinical research, nicotinic acetylcholine receptor antagonists may represent a novel class of therapeutic agents for treating mood disorders...
  10. ncbi request reprint The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder
    David V Sheehan
    Department of Psychiatry, University of South Florida College of Medicine, Tampa, Florida 33613, USA
    Psychopharmacol Bull 40:63-81. 2007
    ..These results must be viewed in the context of the study limitations including its small size, the lack of independence of groups in a switch study, and the limitations of the diary records used...
  11. ncbi request reprint Current approaches to the pharmacologic treatment of anxiety disorders
    David V Sheehan
    University of South Florida College of Medicine, Tampa, FL 33613, USA
    Psychopharmacol Bull 40:98-109. 2007
    ..Preliminary data suggest that tiagabine, the only available SGRI, may also be beneficial in the anxiety disorders. Further research on these novel agents in anxiety disorders is needed...
  12. doi request reprint Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety
    David V Sheehan
    University of South Florida College of Medicine, United States
    J Affect Disord 115:376-85. 2009
    ..Although second generation antipsychotics are being used with increasing frequency in bipolar patients, their anxiolytic effects have not been well studied in this population...
  13. ncbi request reprint Evaluating the economic consequences of early antidepressant treatment discontinuation: a comparison between controlled-release and immediate-release paroxetine
    David V Sheehan
    University of South Florida College of Medicine, Tampa, FL, USA
    J Clin Psychopharmacol 24:544-8. 2004
    ..This is the first study to directly compare treatment discontinuation rates and health care expenditures of a CR selective serotonin reuptake inhibitors with its IR counterpart...
  14. doi request reprint Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
    David V Sheehan
    Depression and Anxiety Disorders Research Institute, University of South Florida College of Medicine, 3515 East Fletcher Ave, Tampa, FL 33613 4706, USA
    J Clin Psychiatry 71:313-26. 2010
    ....
  15. ncbi request reprint Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine
    R Douglas Shytle
    Center for Aging and Brain Repair, Department of Neurosurgery, University of South Florida College of Medicine, 12901 Bruce B Downs Boulevard, Tampa, FL 33613, USA
    Depress Anxiety 16:89-92. 2002
  16. ncbi request reprint Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder
    A A Silver
    University of South Florida College of Medicine, Tampa 33613, USA
    J Am Acad Child Adolesc Psychiatry 40:1103-10. 2001
    ..However, further studies should be conducted to investigate its possible therapeutic effects in subjects with comorbid mood disorders and as an adjunct to neuroleptic medication...
  17. pmc Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders
    Keming Gao
    Department of Psychiatry, Mood and Anxiety Clinic in the Mood Disorders Program, Case Western Reserve University School of Medicine, University Hospitals Case Medical Center, Cleveland, OH 44106, USA
    Expert Rev Neurother 9:1147-58. 2009
    ..However, in contrast to antidepressants and benzodiazepines, the long-term risk and benefit of atypical antipsychotics in the treatment of GAD is yet to be determined...
  18. ncbi request reprint The relationship between functional outcomes and the treatment of anxious and painful somatic symptoms in patients with generalized anxiety disorder
    David V Sheehan
    University of South Florida College of Medicine, Tampa, FL, USA
    Curr Med Res Opin 24:2457-66. 2008
    ..To examine the relationship between global functional impairment and the treatment of anxious symptoms and painful somatic symptoms (PSS) in patients with generalized anxiety disorder (GAD)...
  19. ncbi request reprint False positive results: a challenge for psychiatric screening in primary care
    A C Leon
    Department of Psychiatry, Cornell University Medical College, NY 10021, USA
    Am J Psychiatry 154:1462-4. 1997
    ..The goal of this study was to characterize primary care patients with false positive results on screens for mental disorders...
  20. ncbi request reprint Paroxetine treatment of generalized anxiety disorder
    David V Sheehan
    College of Medicine, University of South Florida, Tampa, FL 33613 4788, USA
    Psychopharmacol Bull 37:64-75. 2003
    ..This article provides an overview of GAD and a discussion of studies of paroxetine treatment in this anxiety disorder...
  21. ncbi request reprint Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders
    David V Sheehan
    University of South Florida College of Medicine, Tampa, Florida, USA
    CNS Drugs 22:963-73. 2008
    ....
  22. ncbi request reprint Improved tolerability and increased length of therapy
    David V Sheehan
    University of South Florida, College of Medicine, USA
    Manag Care 12:23-5. 2003
  23. doi request reprint Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale
    Kathy Harnett Sheehan
    University of South Florida College of Medicine, Tampa, FL 33613, USA
    Int Clin Psychopharmacol 23:70-83. 2008
    ..In addition, the percentages with endpoint scores of zero should be reported...
  24. ncbi request reprint Suicidal ideation in primary care
    M Olfson
    Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
    J Gen Intern Med 11:447-53. 1996
    ..CONCLUSIONS: In these primary care patients, suicidal ideation is strongly associated with mental disorder and mental health-related functional impairment, and can be detected with a single self-report "feeling suicidal" item...
  25. ncbi request reprint Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy
    Jeffery A Lieberman
    Department of Psychiatry, Neurosciences Hospital, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7160, USA
    Neuropsychopharmacology 30:445-60. 2005
    ....
  26. ncbi request reprint Impact of formulary restrictions on the cost-effectiveness of antidepressant treatment
    David V Sheehan
    Department of Psychiatry and Behavioral Medicine, University of South Florida College of Medicine, Tampa, FL, USA
    Manag Care Q 10:21-31. 2002
    ..Assessment of overall cost-effectiveness should not be limited by acquisition costs but should take total healthcare costs into consideration...
  27. ncbi request reprint Generalized anxiety disorder: raising the expectations of treatment
    Christer Allgulander
    Karolinska Institute, Neurotec Department, Huddinge University Hospital, Stockholm
    Psychopharmacol Bull 36:68-78. 2002
    ..Many patients treated with venlafaxine XR achieve and sustain remission from the symptoms of GAD, which is the goal of treatment...
  28. ncbi request reprint The importance of adequate length of antidepressant therapy
    David V Sheehan
    Manag Care 11:13-5; discussion 21-5. 2002
  29. ncbi request reprint Establishing the real cost of depression
    David V Sheehan
    Manag Care 11:7-10; discussion 21-5. 2002
  30. ncbi request reprint Perceived stress in anxiety disorders and the general population: a study of the Sheehan stress vulnerability scale
    Kathryn M Connor
    Anxiety and Traumatic Stress Program, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    Psychiatry Res 151:249-54. 2007
    ..Perceptions of vulnerability to the effects of daily stress are considerably greater in anxiety disorders compared to the general population and also differ within the anxiety disorders...
  31. ncbi request reprint Depression: underdiagnosed, undertreated, underappreciated
    David V Sheehan
    Manag Care 13:6-8. 2004
    ..Rectifying this will involve patients, providers, payers, employers, accrediting agencies, and even governmental entities...